4//SEC Filing
Grant Angus 4
Accession 0001209191-23-045292
CIK 0000818686other
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 4:05 PM ET
Size
5.9 KB
Accession
0001209191-23-045292
Insider Transaction Report
Form 4
Grant Angus
EVP, Business Development
Transactions
- Award
Restricted Share Units
2023-08-09+51,652→ 51,652 total→ Ordinary Shares (51,652 underlying)
Footnotes (3)
- [F1]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F2]Restricted share units were granted on August 9, 2023, with 12,913 vesting on each of August 9, 2024, August 9, 2025, August 9, 2026 and August 9, 2027.
- [F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001988830
Filing Metadata
- Form type
- 4
- Filed
- Aug 9, 8:00 PM ET
- Accepted
- Aug 10, 4:05 PM ET
- Size
- 5.9 KB